- AdventHealth

On Dec. 11, 2020, the U.S. Food and Drug Administration (FDA) announced an emergency use authorization (EUA) for a COVID-19 vaccine developed by Pfizer. An EUA allows for lifesaving medical products to become available during public health emergencies after a rigorous review of scientific evidence and extensive clinical trials proving that the product’s benefits outweigh its known and potential risks.
This authorization means the vaccine can begin its initial limited distribution to the highest risk populations, beginning with health care workers whose roles involve high exposure risk and includes older adults living in long-term care facilities. The vaccine will not initially be available to the general public.
According to the EUA granted by the FDA, the Pfizer vaccine’s clinical trials included approximately 44,000 participants who voluntarily received the vaccine and were closely monitored to measure the vaccine’s safety and effectiveness. These clinical trials have shown the vaccine to be safe and more than 90% effective with no serious side effects.
Full FDA approval of a COVID-19 vaccine requires the completion of all three phases of clinical trials and the submission of exhaustive data that demonstrates its safety and effectiveness.
In preparation for the EUA and potential FDA approval of a vaccine, the AdventHealth COVID-19 Vaccine Task Force has assembled leaders and experts across all areas of the organization to coordinate the clinical and logistical components of each vaccination phase. Each phase of the vaccine’s initial rollout is prioritized by the level of exposure risk and vulnerability to the coronavirus, starting with health care workers and older adults living in long-term care facilities.
“The announcement of this EUA is a significant step in a journey to accrue more tools that help us protect people from COVID-19,” said David Moorhead, MD, chief clinical officer for AdventHealth. “The detailed, publicly available data on this vaccine shows that it can safely and effectively save lives.”
As subsequent phases of the vaccine’s rollout continue toward its eventual availability to the general public, it is imperative to rely only on evidence-based information when making decisions about the COVID-19 vaccine. To help mitigate the pandemic and keep communities safe, the public is urged to take all the proper precautions to protect themselves and others, while being careful to avoid misinformation that can contribute to vaccine hesitancy and high-risk behaviors that can increase potential exposure to the virus.
Recent News
The AdventHealth Orchestra traveled to Washington, D.C., to perform at the Kennedy Center as part of the Capital Orchestra Festival.
For Kay Barnett, leadership goes beyond a job title -- it’s about presence, perseverance and empowering others along the way.
Dr. Sinclair has over 25 years of clinical experience as a practicing physician, including 20 years in progressive leadership roles.
ShorePoint Health Port Charlotte in Port Charlotte, Florida, has joined AdventHealth, one of the largest faith-based health systems in the United States.
This is the first initiative to place AEDs on buses in Orlando and one of the first times the technology has been implemented on public transit in the U.S.
Days before competing in the DAYTONA 500, driver Erik Jones visited a Central Florida elementary school to deliver a big surprise.
Students across seven elementary schools in Kansas received more than 1,500 pairs of new shoes and 3,000 pairs of new socks.
More patients have been helped by an innovative device for stroke survivors at AdventHealth than any other health system in the country.
AdventHealth Centra Care Medical Director Tim Hendrix, MD, explains the symptoms of and the prevention strategies for the "quad-demic" of illnesses going around.
AdventHealth has named Khelsea Bauer president/CEO for AdventHealth DeLand, effective Feb. 23.
AdventHealth has reached a major milestone by welcoming its 100,000th team member to the health system’s skilled and compassionate workforce.
The 3D Motion Lab at AdventHealth Sports Med and Rehab Innovation Tower is the only of its kind in Florida.